NASDAQ:MBOT Microbot Medical (MBOT) Stock Forecast, Price & News $1.33 -0.04 (-2.92%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$1.30▼$1.4150-Day Range$1.33▼$2.6852-Week Range$1.00▼$5.50Volume79,536 shsAverage Volume102,281 shsMarket Capitalization$15.57 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Microbot Medical MarketRank™ ForecastAnalyst Rating0.00 Rating ScoreUpside/Downside501.5% Upside$8.00 Price TargetShort InterestHealthy1.23% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.09) to ($0.64) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.65 out of 5 starsMedical Sector846th out of 963 stocksBiological Products, Except Diagnostic Industry133rd out of 158 stocks 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $8.00, Microbot Medical has a forecasted upside of 501.5% from its current price of $1.33.Amount of Analyst CoverageMicrobot Medical has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.23% of the outstanding shares of Microbot Medical have been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Microbot Medical has recently decreased by 13.76%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MBOT. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Microbot Medical this week, compared to 1 article on an average week.Search Interest3 people have searched for MBOT on MarketBeat in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders13.55% of the stock of Microbot Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.22% of the stock of Microbot Medical is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($1.09) to ($0.64) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Microbot Medical (NASDAQ:MBOT) StockMicrobot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, a robotic system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination. In addition, it provides One & Done Technology, an endovascular robotic system for a range of applications in cardiovascular, peripheral vascular, and neurovascular spaces; and NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. Further, the company offers ViRob, an autonomous crawling micro-robot which can be controlled remotely to navigate and crawl in different natural spaces within the human body, including blood vessels, digestive tract, and respiratory system, as well as artificial spaces, such as shunts, catheters, ports, etc. Additionally, it provides ipCAT, a disposable self-propelled locomotive device that is designed to advance in tubular anatomies. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is headquartered in Hingham, Massachusetts.Read More MBOT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MBOT Stock News HeadlinesSeptember 19, 2023 | americanbankingnews.comHead to Head Analysis: Microbot Medical (NASDAQ:MBOT) vs. Halozyme Therapeutics (NASDAQ:HALO)September 8, 2023 | finance.yahoo.comMicrobot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023September 24, 2023 | Altimetry (Ad)Fraud Expert: Dump these three popular stocksA major (and legal) market manipulation scheme is about to play out. It could cost you a fortune – or double your money. You choose. Find out what he knows, here.August 17, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: AIM ImmunoTech (AIM), Microbot Medical (MBOT)August 16, 2023 | finance.yahoo.comIs Microbot Medical (NASDAQ:MBOT) In A Good Position To Deliver On Growth Plans?August 15, 2023 | finance.yahoo.comMicrobot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical SystemAugust 10, 2023 | finance.yahoo.comMicrobot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory BoardAugust 4, 2023 | benzinga.comChief Financial Officer at Microbot Medical Acquires Company Stock Options Worth 17,500 SharesSeptember 24, 2023 | Altimetry (Ad)Fraud Expert: Dump these three popular stocksA major (and legal) market manipulation scheme is about to play out. It could cost you a fortune – or double your money. You choose. Find out what he knows, here.August 4, 2023 | benzinga.comChairman at Microbot Medical Acquires Company Stock Options Worth 80,000 SharesJuly 11, 2023 | finance.yahoo.comMicrobot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory BoardJune 29, 2023 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct OfferingsJune 29, 2023 | finance.yahoo.comMicrobot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the USJune 28, 2023 | finance.yahoo.comMicrobot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct OfferingsJune 27, 2023 | finance.yahoo.comMicrobot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJune 23, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Its Buy Rating for Microbot Medical (MBOT)June 22, 2023 | finance.yahoo.comMicrobot Medical Expand IP protection in JapanJune 16, 2023 | finance.yahoo.comMicrobot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of EuropeJune 6, 2023 | msn.comHC Wainwright & Co. Reiterates Microbot Medical (MBOT) Buy RecommendationJune 6, 2023 | finance.yahoo.comMicrobot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJune 2, 2023 | finance.yahoo.comMicrobot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJune 2, 2023 | finance.yahoo.comMicrobot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic SystemMay 31, 2023 | finance.yahoo.comLIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory ProcessMay 25, 2023 | finance.yahoo.comLahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human TrialMay 25, 2023 | finance.yahoo.comLahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human TrialMay 24, 2023 | finance.yahoo.comMicrobot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq RulesMay 23, 2023 | msn.comMicrobot Medical Notches Higher after Huge RallySee More Headlines Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address MBOT Company Calendar Last Earnings8/14/2023Today9/24/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MBOT CUSIPN/A CIK883975 Webwww.microbotmedical.com Phone(781) 875-3605Fax781-556-5347Employees18Year Founded2010Price Target and Rating Average Stock Price Forecast$8.00 High Stock Price Forecast$8.00 Low Stock Price Forecast$8.00 Forecasted Upside/Downside+501.5%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($1.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,170,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-171.07% Return on Assets-136.39% Debt Debt-to-Equity RatioN/A Current Ratio7.81 Quick Ratio7.81 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.02 per share Price / Book0.66Miscellaneous Outstanding Shares11,710,000Free Float10,121,000Market Cap$15.57 million OptionableNot Optionable Beta3.22 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Harel Gadot (Age 50)Co-Founder, Pres, CEO & Chairman Comp: $941.8kMr. Yoseph Bornstein (Age 64)Co-Founder & Independent Director Comp: $52.5kMs. Rachel Vaknin (Age 44)Chief Financial Officer Comp: $189.38kDr. Simon Sharon MBA (Age 62)MSc, CTO & GM of Microbot Israel Comp: $461.22kDr. Eyal Morag M.D. (Age 58)Chief Medical Officer & Member of Scientific Advisory Board Comp: $510.43kProf. Moshe Shoham D.Sc. (Age 71)Co-Founder, Scientific Director & Chairman of Scientific Advisory Board More ExecutivesKey CompetitorsEntera BioNASDAQ:ENTXAcorda TherapeuticsNASDAQ:ACORProtara TherapeuticsNASDAQ:TARAHarpoon TherapeuticsNASDAQ:HARPFreeline TherapeuticsNASDAQ:FRLNView All CompetitorsInstitutional OwnershipHilltop Holdings Inc.Bought 19,075 shares on 8/15/2023Ownership: 0.235%Wells Fargo & Company MNBought 12,554 shares on 8/15/2023Ownership: 0.157%BlackRock Inc.Sold 14,746 shares on 8/11/2023Ownership: 1.695%Renaissance Technologies LLCBought 67,300 shares on 8/11/2023Ownership: 1.079%Bank of New York Mellon CorpBought 37,346 shares on 8/3/2023Ownership: 0.649%View All Institutional Transactions MBOT Stock - Frequently Asked Questions What is Microbot Medical's stock price forecast for 2023? 0 Wall Street analysts have issued twelve-month price objectives for Microbot Medical's stock. Their MBOT share price forecasts range from $8.00 to $8.00. On average, they expect the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 501.5% from the stock's current price. View analysts price targets for MBOT or view top-rated stocks among Wall Street analysts. How have MBOT shares performed in 2023? Microbot Medical's stock was trading at $3.01 at the start of the year. Since then, MBOT shares have decreased by 55.8% and is now trading at $1.33. View the best growth stocks for 2023 here. When is Microbot Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our MBOT earnings forecast. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) posted its earnings results on Monday, August, 14th. The biotechnology company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.06. When did Microbot Medical's stock split? Microbot Medical's stock reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE). What is Microbot Medical's stock symbol? Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT." Who are Microbot Medical's major shareholders? Microbot Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.69%), Renaissance Technologies LLC (1.08%), Bank of New York Mellon Corp (0.65%), Hilltop Holdings Inc. (0.23%), Wells Fargo & Company MN (0.16%) and Cutler Group LLC CA (0.00%). View institutional ownership trends. How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Microbot Medical's stock price today? One share of MBOT stock can currently be purchased for approximately $1.33. How much money does Microbot Medical make? Microbot Medical (NASDAQ:MBOT) has a market capitalization of $15.57 million. The biotechnology company earns $-13,170,000.00 in net income (profit) each year or ($1.48) on an earnings per share basis. How can I contact Microbot Medical? Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The official website for the company is www.microbotmedical.com. The biotechnology company can be reached via phone at (781) 875-3605, via email at mpolyviou@evcgroup.com, or via fax at 781-556-5347. This page (NASDAQ:MBOT) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.